How One Stem Cell Could Generate Millions of Tumor-Killing Immune Cells
Researchers in China found a way to generate huge numbers of tumor-killing NK cells from cord-blood stem and progenitor cells, including CAR-engineered versions designed to target cancer more precisely. The study suggests stem cells could become a scalable starting point for next-generation immunotherapy, but it is still an early-stage research advance rather than a treatment available to patients now.